JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elsby, R.
Right arrow Articles by Park, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elsby, R.
Right arrow Articles by Park, B. K.

Vol. 297, Issue 1, 103-113, April 2001

Comparison of the Modulatory Effects of Human and Rat Liver Microsomal Metabolism on the Estrogenicity of Bisphenol A: Implications for Extrapolation to Humans

Robert Elsby, James L. Maggs, John Ashby and B. Kevin Park

Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom (R.E., J.L.M., B.K.P.); and Zeneca Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire, United Kingdom (J.A.)

Bisphenol A [BPA, 2,2-bis(4-hydroxyphenyl)propane], a xenoestrogen, is a monomer for the synthesis of polycarbonate plastics, epoxy resins, and composites. Metabolism of BPA to the monoglucuronide will determine the extent of its estrogenicity in vivo. Investigation of the metabolism of BPA (500 µM) by isolated female rat hepatocytes confirmed the formation of BPA glucuronide as the major metabolite. There was a significant difference (p < 0.05) between the Vmax (mean ± S.E.M., n = 4) of glucuronidation by pooled male or female human (four livers in each case) and immature female rat liver microsomes (5.9 ± 0.4, 5.2 ± 0.3, and 31.6 ± 8.1 nmol/min/mg of protein, respectively). Estrogenic activity of BPA, assessed in a coupled microsomal metabolism-yeast estrogenicity assay, was decreased 3- and 7-fold following glucuronidation by human female and immature female rat liver microsomes, respectively. Incubations of BPA with pooled human or rat liver microsomes, in the presence of NADPH, resulted in the formation of 5-hydroxybisphenol A [2-(4,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)propane], which was 10-fold less potent than BPA in the yeast estrogenicity assay. However, there was insufficient turnover to achieve a significant effect on the estrogenic activity of BPA. Because human liver microsomes did not glucuronidate BPA as extensively as the rat liver microsomes, estrogen target tissues in humans may be subject to greater exposure to BPA than the tissues of the immature female rats used for assessing estrogenicity of xenobiotics.


0022-3565/01/2971-0103$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
JAMAHome page
I. A. Lang, T. S. Galloway, A. Scarlett, W. E. Henley, M. Depledge, R. B. Wallace, and D. Melzer
Association of Urinary Bisphenol A Concentration With Medical Disorders and Laboratory Abnormalities in Adults
JAMA, September 17, 2008; 300(11): 1303 - 1310.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
D. Caserta, L. Maranghi, A. Mantovani, R. Marci, F. Maranghi, and M. Moscarini
Impact of endocrine disruptor chemicals in gynaecology
Hum. Reprod. Update, January 1, 2008; 14(1): 59 - 72.
[Abstract] [Full Text] [PDF]


Home page
Eur J OrthodHome page
T Eliades, V Gioni, D Kletsas, A. Athanasiou, and G Eliades
Oestrogenicity of orthodontic adhesive resins
Eur J Orthod, August 1, 2007; 29(4): 404 - 407.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
V. H. Dang, T. H. Nguyen, K.-C. Choi, and E.-B. Jeung
A Calcium-Binding Protein, Calbindin-D9k, Is Regulated through an Estrogen-Receptor Mediated Mechanism following Xenoestrogen Exposure in the GH3 Cell Line
Toxicol. Sci., August 1, 2007; 98(2): 408 - 415.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. Kitamura, T. Suzuki, S. Sanoh, R. Kohta, N. Jinno, K. Sugihara, S. Yoshihara, N. Fujimoto, H. Watanabe, and S. Ohta
Comparative Study of the Endocrine-Disrupting Activity of Bisphenol A and 19 Related Compounds
Toxicol. Sci., April 1, 2005; 84(2): 249 - 259.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. Y. Domoradzki, L. H. Pottenger, C. M. Thornton, S. C. Hansen, T. L. Card, D. A. Markham, M. D. Dryzga, R. N. Shiotsuka, and J. M. Waechter Jr.
Metabolism and Pharmacokinetics of Bisphenol A (BPA) and the Embryo-Fetal Distribution of BPA and BPA-Monoglucuronide in CD Sprague-Dawley Rats at Three Gestational Stages
Toxicol. Sci., November 1, 2003; 76(1): 21 - 34.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Elsby, N. R. Kitteringham, C. E. Goldring, C. A. Lovatt, M. Chamberlain, C. J. Henderson, C. R. Wolf, and B. K. Park
Increased Constitutive c-Jun N-terminal Kinase Signaling in Mice Lacking Glutathione S-Transferase Pi
J. Biol. Chem., June 13, 2003; 278(25): 22243 - 22249.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
H. Kurebayashi, H. Betsui, and Y. Ohno
Disposition of a Low Dose of 14C-Bisphenol A in Male Rats and Its Main Biliary Excretion as BPA Glucuronide
Toxicol. Sci., May 1, 2003; 73(1): 17 - 25.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J. J. Pritchett, R. K. Kuester, and I. G. Sipes
Metabolism of Bisphenol A in Primary Cultured Hepatocytes from Mice, Rats, and Humans
Drug Metab. Dispos., November 1, 2002; 30(11): 1180 - 1185.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.